Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 13, 2019
Particle Sciences has announced the appointment of Karen Bossert as vice president of operations as part of its ongoing strategy to grow and enhance its manufacturing capabilities.
read more
Thursday, September 13, 2018
Particle Sciences has announced the appointment of Dr. Robert Lee to president.
read more
Monday, November 18, 2019
Lubrizol has announced that its CDMO, Particle Sciences, is to be renamed Lubrizol Life Science Health.
read more
Particle Sciences, Inc. has expanded its development
capabilities to accommodate the increasing demand for biopharmaceutical formulation and
analysis. According to Robert Becker, Vice President Biopharmaceutical Sales and Business
Development ...
read more
Thursday, January 31, 2019
Particle Sciences, a Lubrizol LifeSciences company, has announced its partnership with Indian contract manufacturing organization (CMO), Encube Ethicals.
read more
Thursday, August 02, 2018
LifeSciences and Particle Sciences have received a Notice of Allowance on a device for the delivery of medication to the ear-drum.
read more
Particle Sciences is opening a new commercial drug product manufacturing facility at the end of 2018 at its existing site in Bethlehem, PA.
read more
Particle Testing Authority (PTA) announced the opening of its European laboratory in Munich, Germany.
read more
Partners Group, a global private markets investment manager, acting on behalf of its clients, and the Public Sector Pension Investment Board, one of Canada's largest pension investment managers, have agreed to acquire European medical laboratory ...
read more
Partners Group, a global private markets investment manager, has agreed to acquire global pharmaceutical services provider PCI Pharma Services (PCI) on behalf of its clients.
read more
Tuesday, November 09, 2021
CellVec has been selected as the manufacturer of choice for Australian cell therapy immuno-oncology company Carina Biotech, undertaking the production of GMP-compliant lentivirus constructs for its LGR5 CAR-T.
read more
Wednesday, April 10, 2013
The Society for Clinical Research Sites (SCRS) is pleased to announce that President Christine Pierre has been nominated for the Clinical Trial Business Woman of the Year Award. This prestigious award, granted by the Partnerships in Clinical Trials (...
read more
Passage Bio has entered into a collaboration agreement with Paragon Gene Therapy for the development of a dedicated manufacturing suite at their facility near Baltimore.
read more
Friday, December 11, 2020
Passage Bio and Catalent announced manufacturing operations have commenced to support AAV production for Passage Bio’s lead gene therapy product candidates for the treatment of rare monogenic CNS disorders.
read more
BiondVax Pharmaceuticals announced a patent covering production processes of the Company's M-001 universal influenza vaccine candidate was allowed in the USA and Japan.
read more